Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
News-Medical.Net on MSN4d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
It’s not yet entirely clear why GLP-1 drugs help with addiction, but it may have to do with the overlap between the appetite circuits in the brain with the reward pathways involved in addiction ...
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine, cocaine ...
The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback